BACKGROUND: Virulence factors of Helicobacter pylori are associated with peptic ulcer disease and may be also associated with the efficacy of treatment. AIMS: To determine the relation between the vacA and the cagA status of H pylori, clinical disease, and treatment outcome. PATIENTS: 121 patients with H pylori infection and peptic ulcer disease or functional dyspepsia were treated by quadruple antibiotic therapy in two groups for one and two days, respectively. METHODS: DNA was isolated from gastric antral biopsy specimens, taken before and after treatment, and the vacA and cagA status was determined by polymerase chain reaction and reverse hybridisation. RESULTS:Peptic ulcer disease was significantly associated with the vacA s1 type, and cagA positivity, but not with the vacA m type. Treatment efficacy was significantly higher in patients with peptic ulcer disease, or infected with cagA+/vacA s1 strains. CONCLUSIONS: The strong association between the cagA and vacA status and peptic ulcer disease was confirmed. Cure rates seem to be higher for patients with cagA+/vacA s1 H pylori strains, which is consistent with the higher cure rate observed among ulcer patients compared with functional dyspepsia patients. Therefore, treatment studies may require stratification for presence of ulcers as well as H pylori genotypes.
RCT Entities:
BACKGROUND: Virulence factors of Helicobacter pylori are associated with peptic ulcer disease and may be also associated with the efficacy of treatment. AIMS: To determine the relation between the vacA and the cagA status of H pylori, clinical disease, and treatment outcome. PATIENTS: 121 patients with H pylori infection and peptic ulcer disease or functional dyspepsia were treated by quadruple antibiotic therapy in two groups for one and two days, respectively. METHODS: DNA was isolated from gastric antral biopsy specimens, taken before and after treatment, and the vacA and cagA status was determined by polymerase chain reaction and reverse hybridisation. RESULTS:Peptic ulcer disease was significantly associated with the vacA s1 type, and cagA positivity, but not with the vacA m type. Treatment efficacy was significantly higher in patients with peptic ulcer disease, or infected with cagA+/vacA s1 strains. CONCLUSIONS: The strong association between the cagA and vacA status and peptic ulcer disease was confirmed. Cure rates seem to be higher for patients with cagA+/vacA s1 H pylori strains, which is consistent with the higher cure rate observed among ulcerpatients compared with functional dyspepsiapatients. Therefore, treatment studies may require stratification for presence of ulcers as well as H pylori genotypes.
Authors: R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa Journal: J Clin Microbiol Date: 1990-03 Impact factor: 5.948
Authors: L J van Doorn; C Figueiredo; R Rossau; G Jannes; M van Asbroek; J C Sousa; F Carneiro; W G Quint Journal: J Clin Microbiol Date: 1998-05 Impact factor: 5.948
Authors: L J Van Doorn; C Figueiredo; F Mégraud; S Pena; P Midolo; D M Queiroz; F Carneiro; B Vanderborght; M D Pegado; R Sanna; W De Boer; P M Schneeberger; P Correa; E K Ng; J Atherton; M J Blaser; W G Quint Journal: Gastroenterology Date: 1999-04 Impact factor: 22.682
Authors: A Tucci; L Poli; G F Paparo; P Bocus; T Togliani; C Mazzoni; G F Orcioni; R Agosti; W F Grigioni; S Sottili; G Caletti Journal: Am J Gastroenterol Date: 1998-05 Impact factor: 10.864
Authors: L J van Doorn; C Figueiredo; R Sanna; S Pena; P Midolo; E K Ng; J C Atherton; M J Blaser; W G Quint Journal: J Clin Microbiol Date: 1998-09 Impact factor: 5.948
Authors: A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura Journal: Proc Natl Acad Sci U S A Date: 1993-06-15 Impact factor: 11.205
Authors: T Suzuki; K Matsuo; A Sawaki; K Wakai; K Hirose; H Ito; T Saito; T Nakamura; K Yamao; N Hamajima; K Tajima Journal: Epidemiol Infect Date: 2006-06-02 Impact factor: 2.451
Authors: L J van Doorn; Y Henskens; N Nouhan; A Verschuuren; R Vreede; P Herbink; G Ponjee; K van Krimpen; R Blankenburg; J Scherpenisse; W Quint Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948